This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Calavo Growers (CVGW) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Calavo (CVGW) delivered earnings and revenue surprises of 58.33% and 2.63%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Anheuser-Busch InBev, Constellation Brands, Molson Coors and The Duckhorn Portfolio
by Zacks Equity Research
Anheuser-Busch InBev, Constellation Brands, Molson Coors and The Duckhorn Portfolio are part of the Zacks Industry Outlook article.
4 Alcohol Industry Stocks to Navigate Industry Challenges
by Rajani Lohia
The Zacks Beverages - Alcohol industry is navigating a tough landscape marked by inflation and rising costs for commodities and logistics. Key players like BUD, STZ, TAP and NAPA are positioned to leverage investments in innovation, premiumization and advanced technology platforms.
Brown-Forman B (BF.B) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Brown-Forman B (BF.B) delivered earnings and revenue surprises of -10.87% and 3.87%, respectively, for the quarter ended July 2024. Do the numbers hold clues to what lies ahead for the stock?
The Duckhorn Portfolio, Inc. (NAPA) Meets Q3 Earnings Estimates
by Zacks Equity Research
The Duckhorn Portfolio (NAPA) delivered earnings and revenue surprises of 0% and 0.37%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
Brown-Forman B (BF.B) Beats Q4 Earnings Estimates
by Zacks Equity Research
Brown-Forman B (BF.B) delivered earnings and revenue surprises of 33.33% and 6.11%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
E.l.f. Beauty (ELF) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
e.l.f. Beauty (ELF) delivered earnings and revenue surprises of 51.43% and 9.81%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
The Duckhorn Portfolio, Inc. (NAPA) Matches Q2 Earnings Estimates
by Zacks Equity Research
The Duckhorn Portfolio, Inc. (NAPA) delivered earnings and revenue surprises of 0% and 3.14%, respectively, for the quarter ended January 2024. Do the numbers hold clues to what lies ahead for the stock?
TAP or NAPA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TAP vs. NAPA: Which Stock Is the Better Value Option?
TAP vs. NAPA: Which Stock Is the Better Value Option?
by Zacks Equity Research
TAP vs. NAPA: Which Stock Is the Better Value Option?
Is e.l.f. Beauty (ELF) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how e.l.f. Beauty (ELF) and The Duckhorn Portfolio, Inc. (NAPA) have performed compared to their sector so far this year.
PepsiCo & 4 More Endearing Beverage Stocks Set to Cheer in 2024
by Rajani Lohia
Beverage companies are poised to gain in 2024 from the growing demand for health and functional drinks, as well as low-alcoholic beverages. Embracing innovation and digital expansion bodes well.
Investments Craft PepsiCo's (PEP) Growth Story: Stock to Gain
by Zacks Equity Research
PepsiCo (PEP) is poised to benefit from continued investments in its brands, go-to-market systems, supply chains, manufacturing capacity and digital capabilities to build competitive advantages.
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include The Duckhorn Portfolio (NAPA), PepsiCo (PEP), Lamb Weston (LW), Consolidated Edison (ED) and GameStop (GME).
Digital Initiatives to Keep FEMSA (FMX) Stock in Good Stride
by Zacks Equity Research
FEMSA (FMX) is well-placed for growth through investments in digital and technology-driven initiatives, and continued strength in OXXO Mexico and OXXO Gas.
The Duckhorn Portfolio, Inc. (NAPA) Loses -13.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The Duckhorn Portfolio, Inc. (NAPA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Revitalization Plan Keeps Molson Coors (TAP) on Growth Track
by Zacks Equity Research
Molson Coors (TAP) has been gaining from progress in its revitalization plan, focused on reshaping its product portfolio and growing in emerging markets.
Brown-Forman (BF.B) Q2 Earnings In Line, Stock Dips on View Cut
by Zacks Equity Research
Brown-Forman's (BF.B) Q2 results reflect top-line growth and improved gross margin, partly offset by higher operating expenses.
3 Stocks That Should Be on Your Radar in December
by Shaun Pruitt
November was a very strong month for the stock market and here are three stocks that could have more upside as we enter December.
Earnings Preview: The Duckhorn Portfolio, Inc. (NAPA) Q1 Earnings Expected to Decline
by Zacks Equity Research
The Duckhorn Portfolio, Inc. (NAPA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TAP vs. NAPA: Which Stock Is the Better Value Option?
by Zacks Equity Research
TAP vs. NAPA: Which Stock Is the Better Value Option?
TAP vs. NAPA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TAP vs. NAPA: Which Stock Is the Better Value Option?
Are Options Traders Betting on a Big Move in Duckhorn Portfolio (NAPA) Stock?
by Zacks Equity Research
Investors need to pay close attention to Duckhorn Portfolio (NAPA) stock based on the movements in the options market lately.
The Duckhorn Portfolio, Inc. (NAPA) Q4 Earnings Surpass Estimates
by Zacks Equity Research
The Duckhorn Portfolio, Inc. (NAPA) delivered earnings and revenue surprises of 15.38% and 0.51%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks With Rising P/E to Bet on for Solid Gains
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include Crocs (CROX), AlloVir (ALVR), Arcadia Biosciences (RKDA), The Duckhorn Portfolio (NAPA) and Genuine Parts (GPC).